The PE Ratio as of September 2024 (TTM) for Cabaletta Bio, Inc. (CABA) is -2.23

According to Cabaletta Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.23. This represents a change of -73.78% compared to the average of -8.50 of the last 4 quarters.

Cabaletta Bio, Inc. (CABA) Historical PE Ratio (quarterly & annually)

How has CABA PE Ratio performed in the past?

The mean historical PE Ratio of Cabaletta Bio, Inc. over the last ten years is -146.50. The current -2.23 PE Ratio has changed 52.22% with respect to the historical average. Over the past ten years (40 quarters), CABA's PE Ratio was at its highest in in the September 2022 quarter at -0.43. The PE Ratio was at its lowest in in the December 2019 quarter at -15.54.

Cabaletta Bio, Inc. (CABA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cabaletta Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cabaletta Bio, Inc. (CABA) Average PE Ratio

How has CABA PE Ratio performed in the past?

The current PE Ratio of Cabaletta Bio, Inc. (CABA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cabaletta Bio, Inc. (CABA) PE Ratio vs. Peers

How is CABA’s PE Ratio compared to its peers?

Cabaletta Bio, Inc.’s PE Ratio is less than TCR2 Therapeutics Inc. (0), less than Revolution Medicines, Inc. (-0.44), greater than Black Diamond Therapeutics, Inc. (-13.31), greater than Atreca, Inc. (-3.70), less than Passage Bio, Inc. (-0.04), less than 89bio, Inc. (-0.57), greater than Madrigal Pharmaceuticals, Inc. (-4.84), greater than Pliant Therapeutics, Inc. (-10.23), greater than Arcellx, Inc. (-4.19), greater than Stoke Therapeutics, Inc. (-70.75), greater than Harpoon Therapeutics, Inc. (-7.92), greater than Alector, Inc. (-2.94), greater than Larimar Therapeutics, Inc. (-2.92), greater than Homology Medicines, Inc. (-8.80), less than Day One Biopharmaceuticals, Inc. (-0.01), greater than null (-7.39),

Build a custom stock screener for Cabaletta Bio, Inc. (CABA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cabaletta Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cabaletta Bio, Inc. (CABA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cabaletta Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.